KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Change in Cash (2020 - 2025)

Oscar Health (OSCR) has disclosed Change in Cash for 6 consecutive years, with -$450.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Cash rose 57.47% year-over-year to -$450.5 million, compared with a TTM value of $940.8 million through Sep 2025, up 596.14%, and an annual FY2024 reading of -$340.9 million, down 209.43% over the prior year.
  • Change in Cash was -$450.5 million for Q3 2025 at Oscar Health, down from $363.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $1.5 billion in Q1 2021 and bottomed at -$1.1 billion in Q3 2024.
  • Average Change in Cash over 5 years is $70.0 million, with a median of $212.0 million recorded in 2023.
  • The sharpest move saw Change in Cash skyrocketed 865.71% in 2021, then tumbled 2108.9% in 2022.
  • Year by year, Change in Cash stood at $27.6 million in 2021, then crashed by 2108.9% to -$554.8 million in 2022, then surged by 184.8% to $470.4 million in 2023, then plummeted by 32.15% to $319.2 million in 2024, then crashed by 241.15% to -$450.5 million in 2025.
  • Business Quant data shows Change in Cash for OSCR at -$450.5 million in Q3 2025, $363.0 million in Q2 2025, and $709.2 million in Q1 2025.